Cognitive behavior therapy |
|
|
Clinical Trial: Cognitive Behavioral Treatment of Pediatric Trichotillomania
This study is no longer recruiting patients.
|
Purpose
This study will compare the effectiveness of cognitive-behavior therapy (CBT) to a minimal attention control (AC) condition for treatment of pediatric trichotillomania (TTM).
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Trichotillomania | Behavior: Cognitive-Behavior Therapy | Phase I |
MedlinePlus related topics: Mental Health
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Placebo Control, Single Group Assignment, Efficacy Study
Expected Total Enrollment: 24
Study start: January 2001; Study completion: December 2003
TTM is a persistent impulse control disorder in which the individual acts on urges to pull out his or her own hair. Onset typically occurs by adolescence, and TTM is often associated with significant functional impairment and distress. CBT is a type of psychotherapy designed to change problematic behaviors and thinking. It includes self-monitoring of hair-pulling urges and homework assignments to practice the use of cognitive and behavioral strategies.
Participants are assigned randomly to receive either CBT or AC for 8 weeks. Participants assigned to CBT receive weekly 1-hour sessions of CBT for 8 weeks; participants assigned to AC receive 6 telephone contacts and 2 in-person sessions for 8 weeks. After 8 weeks, CBT participants who respond to treatment enter Phase II, which lasts an additional 8 weeks and includes 4 in-person maintenance sessions. AC participants who are still symptomatic after 8 weeks are offered CBT.
Eligibility
Ages Eligible for Study: 8 Years - 17 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Primary diagnosis of Trichotillomania
- Minimum symptom duration of 6 months
- Presence of a stable parent or guardian
Exclusion Criteria:
- Other primary psychiatric diagnosis
- Bipolar illness, pervasive developmental disorder, thought disorder, current major depression, ADD/ADHD
- Concurrent psychotherapy
- Currently receiving psychotropic medications
Location Information
Pennsylvania
Center for the Treatment and Study of Anxiety, Philadelphia, Pennsylvania, 19104, United States
More Information
Record last reviewed: November 2004
Last Updated: November 9, 2004
Record first received: August 9, 2002
ClinicalTrials.gov Identifier: NCT00043563
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005

Not Signed In -


